Ateganosine

N/A

Report date: 2026/05/02 20:00:18
NMEFirst In Class

Base Information

Drug NameAteganosine
Drug Alias Namesmall molecule telomere targeting agent6-Thio-2'-Deoxyguanosine6-thio-dG2'-DeoxythioguanosineTHIO-101 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTelomere modulators
TargetsTelomere
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesTaiwan +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMAIA Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesMAIA Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A